CNSY
Cerenome, Inc.
Set alert
1.70 USD -0.04 -2.30%
1.66 Day range 1.76
1.56 52-week range 18.00
- YTD
- -86.67%
- 1 year
- -87.17%
- Open
- 1.76
- Prev close
- 1.74
- Mkt cap
- 12.90M
- Vol
- 47.77K
- Avg vol
- 109.26K
- EPS
- -3.36
- P/E
- 0.00
- Div yield
- 0.00%
More statistics
- Low
- 1.66
- High
- 1.76
Financials — quick view
CNSY Revenue — quarterly 411.00K
CNSY Net income — quarterly -9.01M
CNSY EPS — quarterly -1.31
News
- Cerenome Completes Enrollment in Phase 2 ReSPECT-GBM Trial of REYOBIQ™ in Recurrent Glioblastoma
- Cerenome To Report Poster Presentation Of Interim Data From Its Current ReSPECT-LMM Multidose Trial Of REYOBIQ At 31st Annual Meeting And Education Day
- Cerenome to Present Interim Clinical Update on the ReSPECT-LM Trial of Multiple REYOBIQ™ Doses in Leptomeningeal Metastases
- Cerenome Presents New Preclinical Data At 16th Biennial Rivkin Ovarian Cancer Research Symposium Regarding Immunomodulatory Properties Of REYOBIQ
- Lake Street Maintains Buy on Cerenome, Lowers Price Target to $31
- Cerenome Anticipates $1.55M In Payer Billings In Q3
Your note
Sign in to keep a note on CNSY — it syncs with the Stock Master app.